CLINICAL_TRIALS
trial_result
· 2008-09-26
Clinical Trial Update: A Study of BMS-562086 in Patients With Irritable Bowel Syndrome [Phase 2]
Summary
The update confirms the completion of a Phase 2 trial of BMS-562086 in patients with Irritable Bowel Syndrome.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED